Back to MW MARSHALL WACE, LLP
SYRE5 quarters
Position history for MWMARSHALL WACE, LLP's holdings in SPYRE THERAPEUTICS INC
MARSHALL WACE, LLP holds 991,693 shares of SYRE (SPYRE THERAPEUTICS INC), worth $88M as of 2026-Q2. The position was increased (+612.1% shares). SYRE represents 0.1% of MARSHALL WACE, LLP's portfolio.
Current Value
$88M
Current Shares
991,693
Total Value Change
+$87.6M
Total Shares Change
+971,441
Quarter-by-Quarter History
Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP